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Abstract
Tumor microenvironments present significant barriers to anti-tumor agents. Molecules involved in multicellular tumor
microenvironments, however, are difficult to study ex vivo. Here, we generated a matrix-free tumor spheroid model using
the NCI-H226 mesothelioma cell line and compared the gene expression profiles of spheroids and monolayers using
microarray analysis. Microarray analysis revealed that 142 probe sets were differentially expressed between tumor spheroids
and monolayers. Gene ontology analysis revealed that upregulated genes were primarily related to immune response,
wound response, lymphocyte stimulation and response to cytokine stimulation, whereas downregulated genes were
primarily associated with apoptosis. Among the 142 genes, 27 are located in the membrane and related to biologic
processes of cellular movement, cell-to-cell signaling, cellular growth and proliferation and morphology. Western blot
analysis validated elevation of MMP2, BAFF/BLyS/TNFSF13B, RANTES/CCL5 and TNFAIP6/TSG-6 protein expression in
spheroids as compared to monolayers. Thus, we have reported the first large scale comparison of the transcriptional profiles
using an ex vivo matrix-free spheroid model to identify genes specific to the three-dimensional biological structure of
tumors. The method described here can be used for gene expression profiling of tumors other than mesothelioma.
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Introduction
Most human cells are located in and around blood vessels. It is
this architecture that facilitates the delivery of oxygen and
nutrients to the cells and allows for the efficient delivery of drugs
[1], [2]. The proliferation of solid tumor cells forces blood vessels
apart, creating a population of cells distant from vessels. The
resultant tumor microenvironment is recognized as a hallmark of
drug resistance found in solid tumors with studies showing that
drugs can usually penetrate a few cell diameters from blood vessels
into the tumor tissue [1].
The 3D spheroid model has emerged as the method of choice to
study many aspects of malignant cell behavior ex vivo [3], [4].
Spheroids reflect many important properties of solid tumors,
including the development of an extracellular matrix (ECM),
cellular junctions between epithelial cells, and gradients of nutrient
concentration and cell proliferation from the exterior to the center.
Spheroids can develop central necrosis and regions of hypoxia.
Interestingly, Bissell and colleagues for the first time found that all
signal transduction pathways were integrated reciprocally in 3D
laminin-rich ECM on-top cultures of breast cancer while these
pathways appear to be disconnected on 2D monolayer tissue
culture [5]. Ex vivo 3D culture of many other tumor types
(including mesothelioma) has not been evaluated by global gene
expression profiling. The role of a laminin-rich artificial ECM in
both in vitro and in vivo tumor progression and morphology is well-
documented [6], [7], [8]. It is not clear whether an artificial ECM
plays a role in the expression profiling of 3D tumor culture. To
address this issue, we think it is important to evaluate global gene
expression profiling without artificial ECM.
Here, we performed large global gene expression profiling using
an ex vivo matrix-free tumor model. In this way, we focused on
gene expression profiling related to the 3D structure of tumors
independent of artificial ECM. We chose NCI-H226 cells as the
cell model for mesothelioma in the present study given that the cell
line is (a) one of the NCI-60 cancer cell models (http://dtp.nci.nih.
gov/docs/misc/common_files/cell_list.html), and (b) widely used
in mesothelioma research as cell and preclinical tumor models [3],
[9].
Materials and Methods
Cell line
The human mesothelioma cell line, NCI-H226, was obtained
from the American Type Culture Collection (ATCC; Rockville,
MD). The cell line was maintained as adherent monolayer cultures
in RPMI 1640 medium (Invitrogen, Carlsbad, CA) supplemented
with 10% fetal bovine serum (HyClone, Logan, UT), L-glutamine,
pyruvate, nonessential amino acids, and penicillin-streptomycin
(Invitrogen, Carlsbad, CA) and incubated in 5% CO2 with
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5/mL in T-75
tissue culture flasks (Corning Incorporated, Acton, MA). Cells
were harvested and the media were changed twice a week. Cells
were confirmed to be negative for mycoplasma.
Spheroid formation
We made ex vivo tumor spheroids following the protocol
previously described [3], [10]. A 96-well Greiner suspension
culture plate (Sigma, St. Louis, MO) was coated with 50 mLo f
5 mg/mL of poly-HEMA (poly-2-hydroxyethyl methacrylate;
Sigma-Aldrich) in 95% ethanol and evaporated with lid on at
room temperature for 72 hours. Mesothelioma cells were grown to
near confluency and dissociated into single cells with Accutase (BD
Biosciences, San Jose, CA). Each well contained 10,000 cells for
one spheroid. The plate was then centrifuged at 1000 rpm for
10 minutes to initiate cell-cell interaction and incubated at 37uC,
5% CO2 for 24 hours. The spheroids are stable for 48–72 hours
and can be easily transferred using a regular pipette without
dissociating.
Microarray analysis
Microarray analysis experiments were performed in triplicates.
A total of six samples (three for monolayers and three for
spheroids) were analyzed. Total RNA was prepared from NCI-
H226 spheroid and monolayer cells using RNeasy Plus Mini Kit
according to the manufacturer’s instructions (Qiagen, Valencia,
CA). Eight micrograms of total RNA was amplified using the one-
Figure 1. The ex vivo tumor spheroid model. Microscopic images
of monolayers and spheroids of human mesotheliomoa cell line NCI-
H226. 2D: monolayers; 3D: spheroids. Scale: 400 mm.
doi:10.1371/journal.pone.0039556.g001
Table 1. Statistics for microarray with a p value ,0.05.
Fold Changes Number of Probe sets
.2 901 Up: 397
Down: 504
.3 368 Up: 220
Down: 148
.5 142 Up: 112
Down: 30
Gene expression analysis was performed using the Affymetrix Human Genome
U133 Plus 2.0 GeneChip Array (54,675 probe sets). A statistical analysis was
performed using Genespring GX 7.3 software. Data used with a p value ,0.05.
p-value computation was performed using asymptotic, multiple testing
correction (Benjamini-Hochberg).
doi:10.1371/journal.pone.0039556.t001
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micrograms of aliquot of labeled cRNA was fragmented by heat
and ion-mediated hydrolysis, and hybridized to a Human Genome
U133A Plus 2.0 Array (47,000 transcripts and variants including
38,500 human genes; SAIC-Frederick, Frederick, MD). The
arrays were washed and stained in a Fluidics Station 450 and
scanned using a GeneChip Scanner 3000 (Affymetrix, Santa
Clara, CA) and GeneChip Operating Software (Affymetrix).
Expression values for each sample from microarray were
normalized to median expression values. Statistical analyses
including a student’s t-test was performed using Genespring GX
7.3 software (Santa Clara, CA). p values less than 0.05 were
considered significant. Hierarchical clustering was used to group
entities and conditions based on the similarity of expression
profiles. The raw data has been deposited at the National Center
for Biotechnology Information Gene Expression omnibus (GEO)
with accession number GSE37629.
Gene ontology analysis
One hundred forty two transcripts with a five or greater fold
change in expression as well as a student’s t-test output of ,0.05
were used to identify significant differential expression. Gene
ontology enrichment analysis was performed using the Database
for Annotation, Visualization and Integrated Discovery (DAVID)
functional annotation tool (http://david.abcc.ncifcrf.gov). Twenty
seven membrane expressing genes out of 142 transcripts were used
to generate biological function using Ingenuity Pathways Analysis
(IPA; www.ingenuity.com, Ingenuity Systems, Redwood City,
CA). Gene accession numbers were imported into the Ingenuity
Pathway Analysis version 3.1 software, and gene products were
categorized based on location, cellular components, and reported
or suggested biological functions using the software. Mapping to
genetic networks available in the Ingenuity database was also
performed with ranking by score, the probability that a collection
of genes equal to or greater than the number in a network could be
achieved by chance alone. A score of three indicates that there is
a 1/1000 chance that the focus genes are in a network due to
random chance. Therefore, scores of three or higher have a 99.9%
confidence level of not being generated by random chance alone.
This score was used as the cut-off for identifying gene networks.
Western blot analysis
NCI-H226 cells were allowed to grow for 48–72 hours. After
seeding until approximately 60% confluent, 2610
6 monolayer
cells were centrifuged and collected, washed with 1 mL PBS and
resuspended in 100 ml of immunoprecipitation assay buffer
containing 2% SDS and protease inhibitors (‘‘Complete Mini-
EDTA Free’’ protease inhibitor tablet, Roche, Mannheim,
Germany) to lyse cells or spheroids. Four cycles of freezing at
280uC and thawing at 37uC were repeated. Protein lysate was
centrifuged at 10,000 rpm for 1 minute, supernatant was collected
and protein concentration was measured via Coomassie Plus
Protein Assay (Thermo Scientific/Pierce, Rockford, IL). Samples
containing 50 mg of cell lysate per lane were separated by SDS-
PAGE, transferred onto PVDF membranes, and incubated with
primary antibodies. The primary antibodies used include poly-
clonal anti-MMP2 (Santa Cruz Biotechnology, Inc., Santa Cruz,
CA), polyclonal anti-TSG-6 (Santa Cruz Biotechnology, Inc.),
polyclonal anti-RANTES (Santa Cruz Biotechnology, Inc.) and
monoclonal anti-BAFF (R&D Systems, Inc., Minneapolis, MN).
Primary antibodies were detected by secondary goat anti-rabbit
antibodies or anti-mouse antibodies conjugated with horseradish
peroxidase (Jackson ImmunoResearch Laboratories, Inc., West
Grove, PA). Signals were visualized by an enhanced luminol-based
chemiluminescence Western blotting detection kit (GE Health-
care, Piscataway, NJ).
Results
Global gene expressing profiling of 3D mesothelioma
spheroids
To identify genes specific to the 3D structure of tumors, we
cultured mesothelioma spheroids using the NCI-H226 cell line
and compared the global gene expression profiles of NCI-H226
spheroids and monolayers using the Affymetrix Human Genome
U133A Plus 2.0 GeneChip microarrays. We used the NCI-H226
mesothelioma cell line, which was originally isolated from the
pleural fluid of a malignant mesothelioma patient, and may also be
used to grow clinically relevant mesothelioma in mice [9]. We
cultured each spheroid from 10,000 cells. After 24 hours of
incubation, we found the formation of tight spheroid disks with
smooth edges which appeared to be uniform with a diameter of
approximately 700 mm with a thickness of 150 mm (Fig. 1). The
expression of general mesothelioma markers (mesothelin, cytoker-
atin 5/6, calretinin, HBME-1, thrombomodulin, and WT-1) in
spheroids is consistent with those of mesothelioma specimens [3].
Unlike a previous study using breast cancer cells [5], our spheroid
model does not use any matrix [3], [10]. The formation of NCI-
H226 spheroids is stably intact. A statistical summary for the
differentially expressed probe sets between spheroids and mono-
layers is shown in Table 1. Out of 54,675 total probe sets, 1,808
probe sets including 639 upregulated probe sets and 1,115
downregulated probe sets were significantly different between
the two groups (p,0.05) (Table 1).
In this analysis, 142 probe sets (112 upregulated probe sets and
30 downregulated probe sets) in NCI-H226 spheroids compared to
monolayers exhibited at least a five fold-change in expression
levels and a p-value ,0.05 (Table S1). The significantly changed
142 probes were used for hierarchical clustering and gene ontology
analysis. As shown in Figure 2, hierarchical cluster analysis of
significantly differentially expressed genes successfully segregated
NCI-H226 spheroids and monolayers. Samples with similar
patterns of expression of the genes studied were clustered together,
as indicated by the dendrogram. The hierarchical clustering of the
142 genes that were most differentially expressed in the NCI-H226
spheroid cells versus the H226 monolayer cells is illustrated.
Functional analysis of differential genes
To gain insight into the biological significance of the 142 probe
sets identified in our microarray analysis, we interrogated the gene
list for enrichment of known biological categories and performed
Database for Annotation, Visualization and Integrated Discovery
(DAVID) gene ontology analysis (Table 2). DAVID gene ontology
determined the functional categories of significantly affected genes.
DAVID analysis indicated that upregulated genes primarily
affected immune response, wound response, lymphocyte stimula-
Figure 2. Hierarchical clustering of microarray data. Differentially
expressed 142 probe sets with a five or greater fold change in
expression as well as a student’s t-test output of p,0.05 were visualized
by Genespring program. Red indicates higher expression of the gene in
NCI-H226 spheroid cells compared with monolayer cells (up-regulated),
and green indicates lower expression of the gene compared with the
NCI-H226 monolayer cells (down-regulation). Each row represents the
expression level for the transcripts tested for an individual sample. Each
column shows the expression levels for a single transcript tested for
different samples. The entire list of 142 probes is presented in Table S1.
2D: monolayers; 3D: spheroids.
doi:10.1371/journal.pone.0039556.g002
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genes were primarily associated with apoptosis (SOD2, SPHK2
and CIAPIN1). Table 3 shows 27 genes differentially expressed
and associated with cell membrane between NCI-H226 spheroids
and monolayers. We also performed gene ontology analysis using
the Ingenuity Pathway Analysis tool, which yielded 17 genes that
were identified as biologic processes of cellular movement
associated genes, 13 genes that were associated with cell-to cell
signaling and 16 genes that were related with cellular growth and
proliferation and morphology (Table 4). A Venn diagram using
genes in those biological categories shows the identification of
common genes (including MMP2, CCL5, TNFSF13B CCL7,
CSF2 and LCN2) involved in the biologic processes of cellular
movement, cell-to-cell signaling, cellular growth and proliferation
and morphology (Figure 3). CCL5 and TNFSF13B are also known
as RANTES and BAFF/BLyS, respectively.
Western blot validation
To validate gene expression at the protein level, we chose four
cell surface proteins (MMP2, RANTES/CCL5, BAFF/BLyS/
TNFSF13B and TNFAIP6/TSG-6) and performed Western blot
analysis (Table 5). TNFAIP6 (tumor necrosis factor-inducible gene
6 protein) is also known as TSG-6. Our results showed that protein
expression of MMP2, TNFAIP6/TSG-6, RANTES/CCL5 and
BAFF/BLyS/TNFSF13B was higher in NCI-H226 spheroids
compared to monolayers (Fig. 4). The elevation of protein
expression of MMP2, BAFF/BLyS/TNFSF13B, RANTES/
CCL5 and TNFAIP6/TSG-6 validated the microarray results.
Interestingly, the active form of MMP2 was significantly increased
in mesothelioma spheroids compared to monolayers. The high
expression of those proteins in tumor spheroids suggests they may
play a role in tumor formation.
Discussion
The present study has reported the first large scale comparison
of the transcriptional profiles to identify genes specific to the 3D
Figure 3. Venn diagram representing the number of transcripts related to biological functions, cellular movement, cell-to-cell
signaling, cellular growth and proliferation and morphology for spheroids (3D) compared to monolayer (2D) NCI-H226 cells. Venn
diagram incorporates 142 transcripts that have a p,0.05 and at minimum a five-fold change between NCI-H226 spheroids and
monolayer cells. Blue indicates 11 genes for cellular movement, yellow indicates 13 genes for cell-to-cell signaling and interaction, green indicates
16 genes for cellular growth and proliferation, and red indicates 13 morphology-related genes.
doi:10.1371/journal.pone.0039556.g003
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identified 3D-specific genes may have potential as target
candidates for future studies in mesothelioma research, as well as
use in therapeutic and diagnostic applications.
Mesothelioma is an asbestos-related cancer. Cell and molecular
biology studies show that immunological effects of asbestos play an
important role in mesothelioma carcinogenesis [11]. Although the
relationship of the immunological effects of asbestos in regard to
mesothelioma pathogenesis is still poorly understood, asbestos-
induced carcinogenesis and genomic or epigenetic changes have
been studied in mesothelioma cells [12]. In the present study, we
have found that upregulated genes were primarily related to
immune response, wound response, lymphocyte stimulation and
response to cytokine stimulation, whereas downregulated genes
were primarily associated with apoptosis. The downregulation of
apoptosis-related pathway is not surprising, since it has been
suggested that the Bcl-2 signaling pathway of apoptosis plays an
important role in drug resistance in cancer cells. High expression
of Mcl-1 in 3D lung cancer spheroids caused its drug resistance
[13]. In our previous study using the NCI-H226 spheroid model,
we demonstrated an increase of Mcl-1 in mesothelioma spheroids
compared to monolayers, indicating that the mesothelioma
spheroid model acquired Bcl-2 signaling apoptotic resistance [3].
Among the 142 differential genes, 27 are located in the
membrane and related to the biologic processes of cellular
movement, cell-to cell signaling, cellular growth and proliferation
and morphology. We used Western blotting to validate protein
expression of MMP2 (especially the active form), BAFF/BLyS/
TNFSF13B, RANTES/CCL5 and TNFAIP6/TSG-6 in NCI-
H226 spheroids. Matrix metalloproteinases (MMPs) secreted by
malignant mesothelioma, especially MMP2, play crucial roles in
tumor invasion and metastasis [14], [15]. Cytokines and inhibitors
have an up- or down-regulatory effect on MMP2 expression in
mesothelioma, suggesting the clinical value of targeting MMP2 for
management of mesothelioma and its pathogenesis [15]. TSG-6/
TNFAIP6 is a member of the hyaluronan-binding protein family
(also called hyaladherins). This protein is important in the protease
network associated with inflammation. This gene can be induced
by proinflammatory cytokines such as tumor necrosis factor alpha
[16]. Enhanced levels of this protein are reported in human
mesenchymal stromal cells (hMSCs) spheroids [17]. The hyalad-
herins are also involved in ECM stability and cell migration. The
RANTES/CCL5 chemokine plays an active role in recruiting
leukocytes into inflammatory sites. An antibody-based cytokine
array system using supernatant of mesothelioma cell lines and the
corresponding patient’s pleural effusions found that high levels of
RANTES/CCL5 proteins were secreted by mesothelioma cells
[18]. B-cell-activating factor of the tumor necrosis factor (TNF)
family (BAFF; also known as B lymphocyte stimulator), a CD40L-
related molecule produced by myeloid cells, was also identified in
3D mesothelioma spheroids. BAFF signaling in many B-cell
neoplasms stimulates tumor cell growth and survival [19], [20].
Future studies will investigate the roles of these genes in malignant
mesothelioma and evaluate them as potential targets for meso-
thelioma therapy.
We focused only on the genes with a five or greater fold change
in expression, particularly membrane-bound proteins, as potential
therapeutic candidates in mesothelioma. We performed statistical
analysis to define a list of statistically significant genes. This yields
a more manageable list of genes that are both statistically
significant and differentially regulated on a remarkable level. In
this study, a p-value cut-off 0.05 combined with a fold change of
five yielded a gene list of 142 genes differentially expressed in 3D
structure of NCI-H226 mesothelioma spheroids. These gene
changes represent a number of biologically interesting groups.
Although our decision to choose a five-fold cut-off was arbitrary,
similar cut-offs have been commonly used in microarray analysis
[21], [22]. We understand the possibility of missing some
important biological changes with a five-fold cut-off. For example,
Otto Warburg postulated that a high rate of glycolysis is the
fundamental cause of cancer [23]. The hypothesis is called the
‘‘Warburg Effect’’. Recent studies show that PKM2, an isoenzyme
Table 2. The gene ontology (GO) identified by functional analyses.
Up-Regulation
Go Term P Value Fold Enrichment Genes
GO:0006955: Immune response 2.00E204 3.90E+00 CSF3, GBP2, HLA-DRB1 /// HLA-DRB3 /// HLA-DRB4, OAS2,
TNFSF14, CCHLA-DRB1 /// HLA-DRB4, 208306_X_AT,
TNFSF13B, CCL3 /// CCL3L1 /// CCL3L3 /// LOC728830, IL1F9,
GBP1, CCL5, LST1
GO:0009611: Response to wounding 2.90E202 2.90E+00 SOD2, CD36, CCL5, NFKBIZ, TNFAIP6, SAA4, NFKBIZ, CCL3 ///
CCL3L1 /// CCL3L3 /// LOC728830
GO:0031294: Lymphocyte costimulation 3.50E202 5.50E+01 TNFSF14, TNFSF13B
GO:0031295: T cell costimulation 3.50E202 5.50E+01 TNFSF14, TNFSF13B
GO:0034097: Response to cytokine stimulus 4.80E202 8.40E+00 MMP3, CCL5, CDKN2B
Down-Regulation
Go Term P Value Fold Enrichment Genes
GO:0006916: Anti-apoptosis 2.00E202 13.13 SOD2, SPHK2, CIAPIN1
GO:0042981: Regulation of apoptosis 5.00E202 4.49 SOD2, SPHK2, 237398_AT, CIAPIN1
GO:0043067: Regulation of programmed cell death 5.00E202 4.44 SOD2, SPHK2, 237398_AT, CIAPIN1
GO:0010941: Regulation of cell death 5.00E202 4.43 SOD2, SPHK2, 237398_AT, CIAPIN1
Gene ontology was performed using the Database for Annotation, Visualization and Integrated Discovery (DAVID) that were overrepresented (p value ,0.01) in our list
of 142 significantly differentially expressed transcripts (112 up and 30 down) in spheroids compared to monolayers of NCI-H226 cells. Biological process was used as
a category of gene ontology term for this analysis.
doi:10.1371/journal.pone.0039556.t002
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rate of glycolysis in cancer cells [24]. We examined the gene
expression of PKM2 and glucose transporters (GLUT4 and
GLUT1) in spheroids related to the Warburg effect. Interestingly,
we found that expression of PKM2, GLUT4 and GLUT1 was
increased in spheroids by 1.02, 3.15 and 3.46 folds, respectively.
Our results using an ex vivo spheroid model indicate that the
Table 3. Genes differentially expressed in cell membrane between NCI-H226 spheroids and monolayers.
Fold Changes ID Symbol Entrez Gene Name
66.8 206026_s_at TNFAIP6 Tumor necrosis factor, alpha-induced protein 6
39.9 209395_at CHI3L1 Chitinase 3-like 1 (cartilage glycoprotein-39)
20.9 1405_i_at CCL5 Chemokine (C-C motif) ligand 5
16.5 212531_at LCN2 Lipocalin 2
12.9 41469_at PI3 Peptidase inhibitor 3, skin-derived
10.8 204475_at MMP1 Matrix metallopeptidase 1 (interstitial collagenase)
10.4 202357_s_at CFB Complement factor B
10.1 212230_at PPAP2B Phosphatidic acid phosphatase type 2B
8.9 223502_s_at TNFSF13B Tumor necrosis factor (ligand) superfamily, member 13b
8.4 201069_at MMP2 Matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)
7.7 229152_at C4orf7 Chromosome 4 open reading frame 7
7.6 208607_s_at SAA1 Serum amyloid A1
7.4 225817_at CGNL1 Cingulin-like 1
7.4 1553589_a_at PDZK1IP1 PDZK1 interacting protein 1
7.1 210229_s_at CSF2 Colony stimulating factor 2 (granulocyte-macrophage)
6.8 211582_x_at LST1 Leukocyte specific transcript 1
6.7 202499_s_at SLC2A3 Solute carrier family 2 (facilitated glucose transporter), member 3
6.5 205119_s_at FPR1 Formyl peptide receptor 1
6.5 222218_s_at PILRA Paired immunoglobin-like type 2 receptor alpha
6.4 1553293_at MRGPRX3 MAS-related GPR, member X3
6.4 213060_s_at CHI3L2 Chitinase 3-like 2
5.9 215193_x_at HLA-DRB1 Major histocompatibility complex, class II, DR beta 1
5.9 212977_at CXCR7 Chemokine (C-X-C motif) receptor 7
5.5 208075_s_at CCL7 Chemokine (C-C motif) ligand 7
5.4 226189_at ITGB8 Integrin, beta 8
5.1 205828_at MMP3 Matrix metallopeptidase 3 (stromelysin 1, progelatinase)
5.0 237690_at GPR115 G protein-coupled receptor 115
Results presented in this study with NCI-H226 spheroids are compared with monolayer cells. Twenty seven genes out of 142 probes, which are significantly differentially
expressed transcripts between the groups, are in the membrane related group.
doi:10.1371/journal.pone.0039556.t003
Table 4. Ontology analysis of 27 genes located in cell
membrane.
Categories P Value # Molecules
Cellular Movement 7.04E-08 – 1.03E-02 17
Antigen Presentation 2.11E-07 – 9.36E-03 8
Cell-To-Cell Signaling and Interaction 2.11E-07 – 1.06E-02 13
Cellular Growth and Proliferation 7.11E-07 – 9.36E-03 16
Post-Translational Modification 7.78E-06 – 5.47E-03 5
Twenty seven genes located in cell membrane from 142 probes were
functionally annotated to their implication in molecular and cellular functions
using Ingenuity pathway analysis.
doi:10.1371/journal.pone.0039556.t004
Figure 4. Western blot validation. Total protein (50 mg) prepared
from NCI-H226 spheroids (3D) and monolayer (2D) cells were loaded to
SDS-PAGE followed by Western blot analysis.
doi:10.1371/journal.pone.0039556.g004
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ment, and can simply be an adaptation to the 3D structure of
tumors. To make our data available for further analysis in the
future, we deposited the raw data in the GEO public database
(accession number: GSE37629).
In the present study, we used a matrix-free spheroid model to
investigate the changes of global gene expression profiling related
to the 3D biological structure of mesothelioma spheroids. This
method has two important features. First, unlike other methods
utilizing lamine-rich artificial ECM [5], our method allows tumor
cells to form spheroids without artificial matrix. It rules out the
controversial and elusive roles of artificial ECM in spheroid
formation, progression and morphological changes as previously
described [6], [7], [8]. Instead, we allow the mesothelioma
spheroids to produce and utilize their own extracellular molecules
in self-organization of appropriate complex ECM and cell-cell
interactions that mimic functional properties of the corresponding
tumor tissue in vivo. They naturally mimic avascular tumors with
inherent metabolic and proliferative gradients. Our work and that
of other groups have shown that this matrix-free spheroid model is
clinically relevant. We previously demonstrated that matrix-free
NCI-H226 spheroids displayed tumor diagnostic markers consis-
tent with those of mesothelioma specimens, exhibited unique long
and branching microvilli on cell surfaces, a feature characteristic of
well-differentiated malignant mesothelioma in vivo, and expressed
oncogenic cell junction proteins such as E-Cadherin [3]. Broaddus
and colleagues first established this method to grow mesothelioma
spheroids using epithelial (M28 and REN) or sarcomatous
(VAMT) lines [25]. They found that matrix-free mesothelioma
spheroids acquired resistance to a variety of apoptotic stimuli,
including combinations of tumor necrosis factor-related apoptosis-
inducing ligands (TRAIL), ribotoxic stressors, histone deacetylase,
and proteasome inhibitors, that were highly effective against
mesothelioma cells when grown as monolayers. They also showed
that inhibitors of the phosphatidylinositol 3-kinase/Akt/mamma-
lian target of rapamycin (mTOR) pathway, particularly rapamy-
cin, blocked much of the acquired resistance of the spheroids. In
collaboration with Broaddus, we used this method to study
antibody therapy in mesothelioma spheroids [3]. We found that
mesothelioma cells grown as monolayers or as spheroids expressed
comparable levels of mesothelin; however, spheroids were at least
100 times less affected by SS1P, an anti-mesothelin antibody-
bacterial toxin chimeric protein. The penetration of SS1P in
spheroids was limited after four hours. Interestingly, we found
a significant increase in the number of tight junctions in the core
area of spheroids by electron microscopy. Expression of E-
Cadherin, a protein involved in the assembly and sealing of tight
junctions and highly expressed in malignant mesothelioma, was
found significantly increased in spheroids as compared to
monolayers. Moreover, we found that siRNA silencing and
antibody inhibition targeting E-Cadherin could enhance SS1P
therapy in vitro. Taken together, we believe that the matrix-free
spheroid model reflects a clinically relevant in vitro setting. We
understand that some features of malignant mesothelioma that are
not modeled by spheroids include the influence of stroma and
immune cells. Furthermore, spheroid formation is uniform and
highly reproducible from well-to-well, plate-to-plate, and lot-to-lot.
In the present study, we grew spheroids and isolated RNA from
three independent experiments, yet their biological variations (e.g.,
spheroid size, morphology, growth rates) from lot-to-lot were
undetectable. The high quality and reliability of this spheroid
model may be critical for microarray analysis to compare 2D with
3D tumor cell cultures.
This work is one of the first to investigate global gene expression
patterns of mesothelioma using an ex vivo 3D tumor spheroid
model. The method described may allow for further investigations
of the tumor microenvironmental effects on tumor cell biology and
drug resistance, and has applications for studies of other tumor
types. We believe this method has additional applications for
identifying novel molecular targets in tumors. We show in this
work that MMP2, BAFF/BLyS/TNFSF13B, RANTES/CCL5
and TNFAIP6/TSG-6 are highly expressed in 3D mesothelioma
but not in monolayers. Interestingly, MMP2 has already been
suggested as an important molecule involved in mesothelioma
pathogenesis and proposed as a marker for mesothelioma. It will
be of great interest to evaluate other molecules, particularly 27
genes differentially expressed in cell membrane (Table 3), iden-
tified in the present study for their role in mesothelioma biology
and targeted antibody therapy. We will investigate expression of
these genes and their biology in all subtypes of malignant
mesothelioma. It should be valuable to analyze whether these
genes are differentially expressed in epithelioid or sarcomatoid
mesothelioma cells and how they may play a role in mesothelioma
pathogenesis. Some of these genes could be new biomarkers or
therapeutic targets in malignant mesothelioma.
Table 5. Summary of validated proteins.
Symbol Gene Name Fold Change* Location Type(s)
Protein Size
(kDa) Antibodies
MMP2 Matrix metallopeptidase 2
(gelatinase A, 72kDa
gelatinase, 72kDa type IV
collagenase)
8.4 Extracellular Space Peptidase Pro: 72
Active: 63
Rabbit Polyclonal MMP2
(H-76)
TNFAIP6 Tumor necrosis factor,
alpha-induced
protein 6
66.8 Extracellular Space Other 35 Rabbit Polyclonal TSG-6
(FL-277)
CCL5 Chemokine
(C-C motif) ligand 5
20.9 Extracellular Space Cytokine 7.8 Goat Polyclonal RANTES
(C-19)
TNFSF13B Tumor necrosis factor
(ligand) superfamily,
member 13b
8.9 Extracellular Space Cytokine 19.6 Mouse Monoclonal BAFF/BLyS/
TNFSF13B
*Fold changes in mRNA level of spheroid compared to monolayer NCI-H226 cells.
doi:10.1371/journal.pone.0039556.t005
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